Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Envoy Medical, Inc.COCH · Entity 7161 | Director | December 03, 2025 | December 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Envoy Medical, Inc.
Report date December 03, 2025 · Filed December 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.81 · Expires 2035-12-03 | Direct | 25,000 |
Reported balance
After 2025-12-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-03 · Grant · Acquired 25,000 · Balance 25,000 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.40 · Expires 2034-08-08 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2025-12-03 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance 25,000 F1: Options to purchase 6,250 shares vest on 08/08/2025, and the remaining 18,750 shares vest pro rata on the 8th of each month thereafter for 36 consecutive months. |
Filing footnotes · ownership attribution and instrument terms
F1: Options to purchase 6,250 shares vest on 08/08/2025, and the remaining 18,750 shares vest pro rata on the 8th of each month thereafter for 36 consecutive months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 03, 2025 Filed Dec 5, 2025 17:42 UTC | Envoy Medical, Inc. COCH · Entity 7161 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0000914190-25-000051 · form4.xml · derivative · entry 2 Crowe Michael Curtis · CIK 0002026683 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2035-12-03 Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 16:07 UTC | Envoy Medical, Inc. COCH · Entity 7161 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001062993-24-014844 · form4.xml · derivative · entry 1 Crowe Michael Curtis · CIK 0002026683 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2034-08-08 F1 · derivative.exercise_date: Options to purchase 6,250 shares vest on 08/08/2025, and the remaining 18,750 shares vest pro rata on the 8th of each month thereafter for 36 consecutive months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.